Cardiovascular Pathology
Volume 21, Issue 1 , Pages 28-38, January 2012

Proteinase inhibitor 9 is reduced in human atherosclerotic lesion development

Received 30 July 2010; received in revised form 2 December 2010; accepted 12 December 2010. published online 08 February 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This research was funded in part from grants from the Heart and Stroke Foundation of British Columbia and Yukon (HSFBCY) (DJG) and the Canadian Institutes for Health Research (CIHR) (MFA, DJG). Funding sources: AH is grateful for the support from a CIHR Canada Graduate Scholarship Master's Award and the Vanier Canada Graduate Scholarship. DC is funded by the HSFBCY, CIHR/IMPACT, and NSERC Fellowship.

PII: S1054-8807(10)00198-5

doi:10.1016/j.carpath.2010.12.002

Cardiovascular Pathology
Volume 21, Issue 1 , Pages 28-38, January 2012

Article Tools

* Image Usage & Resolution